ERGOMED

News

London, UK, 13 June 2016

Ergomed adds key capabilities through two German acquisitions

London, UK – 13 June 2016: Ergomed plc, (LSE: ERGO or ‘Ergomed’) announces that it has acquired two German service providers to complement and enhance its existing capabilities. These are Dr.Oestreich +Partner GmbH (‘O+P’), a full service contract research organisation based in Cologne and, Gesellschaft für angewandte Statistik + Datenanalyse mbH (‘GASD’),…


London, UK, 23 May 2016

Ergomed plc: Result of General Meeting

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS PROHIBITED.

Result of General Meeting

London, UK 23…


London, UK, 16 May 2016

Placing Update: Exercise of Joint Bookrunners’ Option

Ergomed plc (“Ergomed” or the “Company”, AIM: ERGO) a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that further to the Placing announced on 04 May 2016, Stifel Nicolaus Europe Limited and Numis Securities Limited as joint bookrunners, have exercised the…


London, UK, 04 May 2016

Proposed acquisition of Haemostatix Limited

London, UK 04 May 2016:  Ergomed plc, (“Ergomed” or the “Company”, AIM: ERGO) a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces the proposed acquisition of Haemostatix Limited (“Acquisition”), a company focused on developing a pipeline of topical…


London, UK, 12 April 2016

Unaudited Preliminary Results for the year ended 31 December 2015

Strong financial performance coupled with an extensive backlog

London, UK12 April 2016:  Ergomed plc, (‘Ergomed’, AIM: ERGO) a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces its Preliminary Results for the year ended 31 December…


Page 10 of 19« First...89101112...Last »
Translate »